Ann E. Eakin
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- Biochemical and Molecular Research 22
-
- SARS-CoV-2 and COVID-19 Research 4
- Co-authors
- Charles S. Craik (8 shared papers)Sydney P. Craig (18 shared papers)James Hobson McKerrow (5 shared papers)Pamela J. Focia (9 shared papers)Robert J. Fletterick (3 shared papers)Juan Carlos Engel (3 shared papers)G Harth (1 shared paper)Alea A. Mills (1 shared paper)
- Journals
- Antimicrobial Agents and Chemotherapy (8 papers)Biochemistry (5 papers)Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics (3 papers)Journal of Biological Chemistry (3 papers)Journal of Antimicrobial Chemotherapy (2 papers)
- Partner nations
- United StatesPuerto RicoSweden
In The Last Decade
Ann E. Eakin
57 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 88
- Molecular Medicine 242
- Infectious Diseases 344
- Epidemiology 549
- Pharmacology 257
- Cancer Research 214
Countries citing papers authored by Ann E. Eakin
This map shows the geographic impact of Ann E. Eakin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann E. Eakin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann E. Eakin more than expected).
Fields of papers citing papers by Ann E. Eakin
This network shows the impact of papers produced by Ann E. Eakin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann E. Eakin. The network helps show where Ann E. Eakin may publish in the future.
Co-authors
The 25 scholars most cited alongside Ann E. Eakin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1992 | 249 | |
| 2 | 1995 | 226 | |
| 3 | 2019 | 159 | |
| 4 | 2011 | 119 | |
| 5 | 1989 | 111 | |
| 6 | 2011 | 110 | |
| 7 | 2022 | 106 | |
| 8 | 1993 | 88 | |
| 9 | 2015 | 87 | |
| 10 | 2000 | 84 | |
| 11 | 2013 | 78 | |
| 12 | 1990 | 77 | |
| 13 | 1993 | 75 | |
| 14 | 2010 | 74 | |
| 15 | 2015 | 74 | |
| 16 | 2014 | 71 | |
| 17 | 2020 | 70 | |
| 18 | 1998 | 69 | |
| 19 | 1999 | 64 | |
| 20 | 2000 | 56 |
About Ann E. Eakin
Ann E. Eakin is a scholar working on Molecular Biology, Infectious Diseases, Pharmacology, Epidemiology and Computational Theory and Mathematics, having authored 58 papers that have together received 2.7k indexed citations. Recurring topics across this work include Biochemical and Molecular Research (22 papers), Trypanosoma species research and implications (7 papers), Enzyme Structure and Function (6 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers), Synthesis and Biological Evaluation (5 papers), Computational Drug Discovery Methods (5 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and Protease and Inhibitor Mechanisms (4 papers). The work is most often cited by research in Molecular Medicine (242 citations), Infectious Diseases (344 citations), Epidemiology (549 citations), Pharmacology (257 citations) and Cancer Research (214 citations). Ann E. Eakin has collaborated with scholars based in United States, Puerto Rico and Sweden. Frequent co-authors include Charles S. Craik, Sydney P. Craig, James Hobson McKerrow, Pamela J. Focia, Robert J. Fletterick, Juan Carlos Engel, G Harth, Alea A. Mills, J.H. McKerrow and Judy A. Sakanari. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Biochemistry, Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, Journal of Biological Chemistry and Journal of Antimicrobial Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.